Quaker Chemical (NYSE:KWR) Upgraded at Zacks Investment Research

Zacks Investment Research upgraded shares of Quaker Chemical (NYSE:KWR) from a sell rating to a hold rating in a research note released on Tuesday, Zacks.com reports.

According to Zacks, “Quaker Chemical Corporation develops, produces and markets a range of formulated chemical specialty products for various heavy industrial and manufacturing applications and, in addition, offers and markets chemical management services (CMS). The Company operates in three segments: Metalworking process chemicals, Coatings and Other chemical products. The Metalworking process chemicals segment includes industrial process fluids for various heavy industrial and manufacturing applications. Coatings segment includes temporary and permanent coatings for metal and concrete products and chemical milling maskants. “

KWR has been the subject of several other reports. Sidoti dropped their price target on Quaker Chemical from $176.00 to $156.00 and set a neutral rating for the company in a report on Monday, October 21st. Jefferies Financial Group set a $153.00 price target on Quaker Chemical and gave the stock a hold rating in a report on Monday, October 21st. Finally, Janney Montgomery Scott reissued a buy rating and set a $204.00 price target on shares of Quaker Chemical in a report on Wednesday, October 2nd. Five equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the company. The stock presently has a consensus rating of Hold and an average target price of $172.00.

NYSE:KWR opened at $169.61 on Tuesday. The stock has a market cap of $2.99 billion, a P/E ratio of 85.66, a PEG ratio of 1.75 and a beta of 1.51. The stock has a 50 day simple moving average of $163.67 and a 200 day simple moving average of $162.59. The company has a current ratio of 2.10, a quick ratio of 1.59 and a debt-to-equity ratio of 0.71. Quaker Chemical has a 1-year low of $141.79 and a 1-year high of $224.30.

Quaker Chemical (NYSE:KWR) last released its quarterly earnings results on Tuesday, November 12th. The specialty chemicals company reported $1.56 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.40 by $0.16. The business had revenue of $325.10 million during the quarter, compared to analysts’ expectations of $324.93 million. Quaker Chemical had a return on equity of 13.39% and a net margin of 2.54%. The firm’s revenue for the quarter was up 46.4% compared to the same quarter last year. During the same period last year, the firm posted $1.60 EPS. As a group, sell-side analysts forecast that Quaker Chemical will post 5.87 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, January 17th will be paid a dividend of $0.385 per share. The ex-dividend date of this dividend is Thursday, January 16th. This represents a $1.54 dividend on an annualized basis and a yield of 0.91%. Quaker Chemical’s dividend payout ratio (DPR) is presently 25.50%.

In related news, insider (Steve) Brockhurst Stephen 250,000 shares of the business’s stock in a transaction that occurred on Monday, November 25th. 2.90% of the stock is owned by company insiders.

A number of institutional investors have recently bought and sold shares of KWR. Price T Rowe Associates Inc. MD increased its stake in Quaker Chemical by 36.4% during the 2nd quarter. Price T Rowe Associates Inc. MD now owns 1,426,977 shares of the specialty chemicals company’s stock worth $289,505,000 after acquiring an additional 380,431 shares during the period. Nuveen Asset Management LLC bought a new position in Quaker Chemical during the 2nd quarter worth $10,807,000. Atria Investments LLC bought a new position in Quaker Chemical during the 2nd quarter worth $3,475,000. GW&K Investment Management LLC increased its stake in Quaker Chemical by 26.1% during the 3rd quarter. GW&K Investment Management LLC now owns 195,092 shares of the specialty chemicals company’s stock worth $30,851,000 after acquiring an additional 40,350 shares during the period. Finally, Morgan Stanley increased its stake in Quaker Chemical by 77.8% during the 2nd quarter. Morgan Stanley now owns 61,166 shares of the specialty chemicals company’s stock worth $12,409,000 after acquiring an additional 26,770 shares during the period. Hedge funds and other institutional investors own 74.76% of the company’s stock.

Quaker Chemical Company Profile

Quaker Chemical Corporation develops, produces, and markets various formulated chemical specialty products for a range of heavy industrial and manufacturing applications in North America, Europe, the Middle East, Africa, the Asia/Pacific, and South America. The company's products include rolling lubricants used by manufacturers of steel in the hot and cold rolling of steel, and aluminum in the hot rolling of aluminum; machining and grinding compounds for use in cutting, shaping, and grinding metal parts; hydraulic fluids for steel, metalworking, and other customers to operate hydraulic equipment; corrosion preventives to protect metals during manufacture, storage, and shipment; and specialty greases used in automotive and aerospace production processes, steel manufacturing, and various other applications.

See Also: What is Forex?

Get a free copy of the Zacks research report on Quaker Chemical (KWR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Quaker Chemical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quaker Chemical and related companies with MarketBeat.com's FREE daily email newsletter.